Articles

Results 1 to 5 of 17
Most popular |Most recent


In brief: anticompetitive agreements in the pharmaceutical sector in Finland

Finland - July 1 2021 The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in Finland, including the assessment framework and special issues with vertical agreements.

Kiti Karvinen.

At a glance: pharmaceutical merger review in Finland

Finland - July 1 2021 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in Finland, including review triggers and thresholds.

Kiti Karvinen.

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in Finland

Finland - July 1 2021 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Finland, including IP rights abuse and pricing conduct.

Kiti Karvinen.

Spotlight: medicine and medical device pricing and reimbursement in Finland

Finland - March 24 2021 An examination of the key legal and practical issues surrounding the pricing and reimbursement of medicinal products and medical devices in Finland.

Hilma-Karoliina Markkanen.

In review: the life sciences regulatory regime in Finland

Finland - March 24 2021 This article reviews the essential regulatory considerations surrounding medicines and medical devices in Finland, including clinical trials and marketing authorisations.

Hilma-Karoliina Markkanen.